Ovintiv price target raised to $59 from $57 at UBS

UBS analyst Josh Silverstein raised the firm’s price target on Ovintiv (OVV) to $59 from $57 and keeps a Buy rating on the shares. The firm says the company’s streamlined portfolio improves its outlook.